Steven Lichtman
Stock Analyst at Oppenheimer
(4.44)
# 353
Out of 4,412 analysts
41
Total ratings
54.29%
Success rate
22.56%
Average return
Main Sectors:
Top Industries:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANGO AngioDynamics | Upgrades: Outperform | $12 | $5.82 | +106.19% | 2 | Apr 5, 2024 | |
| RXST RxSight | Maintains: Outperform | $54 → $61 | $53.26 | +14.53% | 6 | Feb 29, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $82 → $87 | $75.09 | +15.86% | 1 | Feb 29, 2024 | |
| MDT Medtronic | Maintains: Perform | $89 → $92 | $80.86 | +13.78% | 6 | Feb 21, 2024 | |
| BSX Boston Scientific | Maintains: Perform | $58 → $68 | $72.50 | -6.21% | 2 | Feb 1, 2024 | |
| BWAY BrainsWay | Maintains: Outperform | $5.5 → $6 | $5.06 | +18.58% | 3 | Nov 16, 2023 | |
| MODD Modular Medical | Reiterates: Outperform | $3.5 | $1.62 | +116.05% | 2 | Sep 19, 2023 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Outperform | $157 | $121.71 | +29.00% | 3 | Aug 2, 2023 | |
| PODD Insulet | Upgrades: Outperform | $300 → $275 | $170.26 | +61.52% | 2 | Jan 31, 2022 | |
| ALC Alcon | Initiates: Perform | n/a | $78.72 | - | 1 | Oct 1, 2021 | |
| DXCM DexCom | Maintains: Outperform | n/a | $125.81 | - | 3 | Jul 30, 2021 | |
| SYK Stryker | Maintains: Perform | n/a | $338.87 | - | 1 | Jul 28, 2021 | |
| GKOS Glaukos | Downgrades: Perform | n/a | $97.20 | - | 3 | Jul 14, 2021 | |
| STAA STAAR Surgical Company | Initiates: Perform | n/a | $47.43 | - | 1 | Jul 9, 2021 | |
| COO The Cooper Companies | Maintains: Perform | $83 → $85 | $89.89 | -5.44% | 3 | Sep 4, 2020 | |
| MNKD MannKind | Initiates: Outperform | n/a | $4.26 | - | 1 | Dec 24, 2019 | |
| AVGR Avinger | Downgrades: Perform | n/a | $3.77 | - | 1 | Apr 12, 2017 |
AngioDynamics
Apr 5, 2024
Upgrades: Outperform
Price Target: $12
Current: $5.82
Upside: +106.19%
RxSight
Feb 29, 2024
Maintains: Outperform
Price Target: $54 → $61
Current: $53.26
Upside: +14.53%
Merit Medical Systems
Feb 29, 2024
Maintains: Outperform
Price Target: $82 → $87
Current: $75.09
Upside: +15.86%
Medtronic
Feb 21, 2024
Maintains: Perform
Price Target: $89 → $92
Current: $80.86
Upside: +13.78%
Boston Scientific
Feb 1, 2024
Maintains: Perform
Price Target: $58 → $68
Current: $72.50
Upside: -6.21%
BrainsWay
Nov 16, 2023
Maintains: Outperform
Price Target: $5.5 → $6
Current: $5.06
Upside: +18.58%
Modular Medical
Sep 19, 2023
Reiterates: Outperform
Price Target: $3.5
Current: $1.62
Upside: +116.05%
Zimmer Biomet Holdings
Aug 2, 2023
Reiterates: Outperform
Price Target: $157
Current: $121.71
Upside: +29.00%
Insulet
Jan 31, 2022
Upgrades: Outperform
Price Target: $300 → $275
Current: $170.26
Upside: +61.52%
Alcon
Oct 1, 2021
Initiates: Perform
Price Target: n/a
Current: $78.72
Upside: -
DexCom
Jul 30, 2021
Maintains: Outperform
Price Target: n/a
Current: $125.81
Upside: -
Stryker
Jul 28, 2021
Maintains: Perform
Price Target: n/a
Current: $338.87
Upside: -
Glaukos
Jul 14, 2021
Downgrades: Perform
Price Target: n/a
Current: $97.20
Upside: -
STAAR Surgical Company
Jul 9, 2021
Initiates: Perform
Price Target: n/a
Current: $47.43
Upside: -
The Cooper Companies
Sep 4, 2020
Maintains: Perform
Price Target: $83 → $85
Current: $89.89
Upside: -5.44%
MannKind
Dec 24, 2019
Initiates: Outperform
Price Target: n/a
Current: $4.26
Upside: -
Avinger
Apr 12, 2017
Downgrades: Perform
Price Target: n/a
Current: $3.77
Upside: -